DE2504387A1 - Arzneimittelgemisch - Google Patents

Arzneimittelgemisch

Info

Publication number
DE2504387A1
DE2504387A1 DE19752504387 DE2504387A DE2504387A1 DE 2504387 A1 DE2504387 A1 DE 2504387A1 DE 19752504387 DE19752504387 DE 19752504387 DE 2504387 A DE2504387 A DE 2504387A DE 2504387 A1 DE2504387 A1 DE 2504387A1
Authority
DE
Germany
Prior art keywords
alkaloid
vincamine
ergot
blood
calculated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19752504387
Other languages
German (de)
English (en)
Inventor
Philippe Borredon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unilever NV
Original Assignee
Unilever NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever NV filed Critical Unilever NV
Publication of DE2504387A1 publication Critical patent/DE2504387A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE19752504387 1974-02-04 1975-02-03 Arzneimittelgemisch Withdrawn DE2504387A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5068/74A GB1494625A (en) 1974-02-04 1974-02-04 Pharmaceutical preparations

Publications (1)

Publication Number Publication Date
DE2504387A1 true DE2504387A1 (de) 1975-08-07

Family

ID=9789155

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752504387 Withdrawn DE2504387A1 (de) 1974-02-04 1975-02-03 Arzneimittelgemisch

Country Status (6)

Country Link
US (1) US3987173A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE825188A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2504387A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2259609B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1494625A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL7501278A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3227122A1 (de) * 1982-07-20 1984-01-26 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Stabile loesungen von mutterkornalkaloiden

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU544429B2 (en) * 1979-11-28 1985-05-30 Sandoz Ag Compositions of ergots
US7771746B2 (en) * 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
RU2525433C2 (ru) * 2011-10-05 2014-08-10 Общество С Ограниченной Ответственностью "Фарма Старт" Лекарственный препарат винкамина в форме матричных таблеток для улучшения мозгового кровообращения и способ его изготовления

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2108993A1 (en) 1970-10-28 1972-05-26 Forschag Vincamine alkaloid fraction - with sedative and vasoregulating effect

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3227122A1 (de) * 1982-07-20 1984-01-26 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Stabile loesungen von mutterkornalkaloiden

Also Published As

Publication number Publication date
US3987173A (en) 1976-10-19
GB1494625A (en) 1977-12-07
BE825188A (fr) 1975-08-04
NL7501278A (nl) 1975-08-06
FR2259609A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-08-29
FR2259609B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1978-07-21

Similar Documents

Publication Publication Date Title
DE2856393C2 (de) Arzneimittel zur Behandlung von Morbus Parkinson
DE3688296T2 (de) Arzneimittel zur behandlung von erbrechen.
DE69226624T3 (de) Zusammensetzung, die eine tramadol-verbindung und acetaminophen enthält, und ihre verwendung
DE19814838C2 (de) Indolyl-3-glyoxylsäure-Derivate mit Antitumorwirkung
DE2828658A1 (de) Verfahren zur photometrischen bestimmung der untereinheit b der creatin- kinase und reagens hierfuer
EP0214620B1 (de) Transdermale Applikationsform von Diltiazem
DE3607381A1 (de) Verwendung von diphenylhydantoin und seinen derivaten zur behandlung von immunerkrankungen
DE69829202T2 (de) Verwendung von mirtazapine zur herstellung eines medikaments zur behandlung von schlafapnoen
DE3130912A1 (de) Analgetische arzneimittelkombination
DE2504387A1 (de) Arzneimittelgemisch
DE2716402A1 (de) 7-(2,3-dihydroxypropyl)-1,3-di-n- propylxanthin, verfahren zu seiner herstellung und diese verbindung enthaltende arzneimittel
DE3525390C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE2357074A1 (de) Gefaesserweiterndes und sympatholytisches arzneimittel
DD297557A5 (de) Verwendung von dopamin-autorezeptor-agonisten bei der behandlung von drogenabhaengigkeit
DE3887426T2 (de) Eperisone als Hypotonikum.
DE2314387C3 (de) Arzneimittel zur Behandlung bösartiger Neubildungen
DD283931A5 (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von herzrhythmusstoerungen
DE1617822A1 (de) Neues Kombinationspraeparat
DE2351609A1 (de) Neue pharmazeutische zubereitungen
DE2145359A1 (de) Neue Phthalazindenvate
DE1792271C3 (de) Blutdrucksenkendes Arzneimittel
DE3432974A1 (de) Arzneimittel zur prophylaxe oder therapie der negativen shizophreniesymtome bei menschen
DE2929027A1 (de) Saeureadditionssalze rechtsdrehender ergot-alkaloide, verfahren zu deren herstellung sowie ihre verwendung als arzneimittel
DE3490243C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE1670061C (de) 2 (2' Pyndyloxy)-athylguamdin und Verfahren zu dessen Herstellung

Legal Events

Date Code Title Description
8130 Withdrawal